Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 4
1958 1
1959 2
1960 4
1961 1
1962 1
1968 1
1969 5
1970 2
1971 1
1972 3
1973 5
1974 1
1975 2
1976 2
1977 1
1978 3
1979 5
1980 4
1981 5
1982 6
1983 3
1984 4
1985 4
1986 5
1987 5
1988 1
1989 1
1990 1
1991 5
1992 6
1993 3
1994 5
1995 6
1996 8
1997 4
1998 8
1999 8
2000 13
2001 10
2002 16
2003 11
2004 24
2005 13
2006 10
2007 13
2008 16
2009 24
2010 17
2011 22
2012 26
2013 24
2014 26
2015 22
2016 32
2017 27
2018 21
2019 24
2020 22
2021 17
2022 12
2023 7
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Results by year

Filters applied: . Clear all
Page 1
An Update on Refractory Hypertension.
Matanes F, Khan MB, Siddiqui M, Dudenbostel T, Calhoun D, Oparil S. Matanes F, et al. Among authors: calhoun d. Curr Hypertens Rep. 2022 Jul;24(7):225-234. doi: 10.1007/s11906-022-01185-6. Epub 2022 Apr 6. Curr Hypertens Rep. 2022. PMID: 35384577 Free PMC article. Review.
Treatment of Resistant and Refractory Hypertension.
Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Acelajado MC, et al. Among authors: calhoun da. Circ Res. 2019 Mar 29;124(7):1061-1070. doi: 10.1161/CIRCRESAHA.118.312156. Circ Res. 2019. PMID: 30920924 Free PMC article. Review.
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB; American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council. Carey RM, et al. Among authors: calhoun da. Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084. Hypertension. 2018. PMID: 30354828 Free PMC article.
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
SPRINT Research Group; Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius WT. SPRINT Research Group, et al. N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281. N Engl J Med. 2021. PMID: 34010531 Free PMC article. Clinical Trial.
A controlled trial of renal denervation for resistant hypertension.
Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. Bhatt DL, et al. N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29. N Engl J Med. 2014. PMID: 24678939 Free article. Clinical Trial.
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL; SYMPLICITY HTN-3 Steering Committee Investigators. Bhatt DL, et al. Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18. Lancet. 2022. PMID: 36130612 Clinical Trial.
Resistant Hypertension: An Update.
Calhoun DA, Schiffrin EL, Flack JM. Calhoun DA, et al. Am J Hypertens. 2019 Jan 1;32(1):1-3. doi: 10.1093/ajh/hpy156. Am J Hypertens. 2019. PMID: 30407514 No abstract available.
Advances in resistant hypertension.
Calhoun DA. Calhoun DA. Ann Transl Med. 2018 Aug;6(15):294. doi: 10.21037/atm.2018.07.21. Ann Transl Med. 2018. PMID: 30211182 Free PMC article. No abstract available.
547 results